Bladder Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting

Featuring slide presentations and related discussion from Drs Petros Grivas, Daniel P Petrylak and Arlene Siefker-Radtke, including the following topics: Key Data Supporting the Use of Antibody-Drug Conjugates in Bladder Cancer — Daniel P Petrylak, MD (0:00) Approved and Investigational FGFR-Targeted Therapies in Advanced Urothelial Bladder Cancer — Arlene Siefker-Radtke, MD (33:01) Current and Future Role of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer — Petros Grivas, MD, PhD (1:21:15) CME information and select publications